By Karuna Thapa
Kathmandu, February 16
The first anti-cancer medicine developed in Nepal is now available. Tizig Pharma Pvt. Ltd. produces anti-cancer medications, according to Shailesh Vaidya, the company’s director.He stated that anti-cancer medications decided to hit the market when the Department of Drug Management granted a market license.
Vaidya claims to be the first firm in Nepal to manufacture anti-cancer treatments and distribute them to both domestic and international markets. ‘Three molecules have been granted market permits by the department for distribution in Nepal.’ Director Vaidya announced that another chemical has been cleared for export. Tezig Pharma is a Nepalese pharmaceutical firm that was founded and is run with foreign capital after negotiating a technology transfer agreement with SP Acure Lab (SPAL) in Hyderabad, India.
We set it up in compliance with World Health Organization (WHO) standards and Nepal’s Technology Transfer Act,’ Vaidya explained. The World Health Organization’s technology transfer requirements were followed, and the operation’s norms and regulations would be observed as well. He stated that the provisions for the manufacture, analysis, and distribution of the medicine will be in compliance with WHO recommendations, Nepal’s Medicines Act and regulations, and the stipulations contained in the text of the linked medicines.
Tijig has received production approval from the department for 27 compounds, according to Vaidya. There are five pharmacopeia and one non-pharmacopeia among them. According to Vaidya, some of these drug production permits are for drug export. He stated that the items now on the market are tablets and capsules. In the near future, he also intends to produce injection-based medications.
According to Tizig Pharma’s Executive Director, Vaidya, pharmaceutical production, analysis, and other processes are carried out in accordance with World Health Organization recommendations, Nepal’s Medicines Act and regulations, and provisions contained in the text of relevant medicines. He claims that there is a firm foundation in quality control and regulation of medications because SPAL (WHO GMP, EUGMP Certified) is also maintained and monitored. He claimed that the price of domestically manufactured medicine would be lower than that of imported medicine, and that the price of Tezig Pharma’s anticancer medicine would be lower than that of imported medicine.
“Patients in Nepal had to bring medicines from overseas and take them until today. That responsibility will now be lifted “he stated We will definitely provide some relief to the patients if the same drug is developed in Nepal. Another advantage is that if it is manufactured in Nepal, medicines would be consistent and readily available. ‘I don’t think there will be a scarcity of drugs,’ he said.
